BMO
AGN

Beck Mack & Oliver’s Allergan plc AGN Stock Holding History

Beck Mack & Oliver’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-772
Closed -$207K – 286
2016
Q1 		$207K Hold
772
– – 0.01% 255
2015
Q4 		$241K Sell
772
-6
-0.8% -$1.79K 0.01% 250
2015
Q3 		$211K Sell
778
-147
-16% -$45.2K 0.01% 285
2015
Q2 		$281K Sell
925
-140
-13% -$41.8K 0.01% 282
2015
Q1 		$317K Buy
+1,065
New +$304K 0.01% 275

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Beck Mack & Oliver's AGN Position: Q2 2016 in Review

Beck Mack & Oliver sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 772 shares — an estimated $207K sold.

Beck Mack & Oliver first reported a position in AGN in Q1 2015 and held it in 5 quarters. The position peaked at $317K in Q1 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Beck Mack & Oliver reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
  • Beck Mack & Oliver sold 772 Allergan plc shares in Q2 2016, an estimated $207K.
  • Beck Mack & Oliver first reported a position in Allergan plc in Q1 2015 and held it in 5 quarters.
  • Beck Mack & Oliver's Allergan plc position peaked at $317K in Q1 2015.
  • 1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Beck Mack & Oliver's 13F filing for Q2 2016, filed 29 Jul 2016.